These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30268928)

  • 1. A glucuronoxylomannan-like glycan produced by Trichosporon mucoides.
    Zimbres ACG; Albuquerque PC; Joffe LS; Souza TN; Nimrichter L; Frazão SO; Albuquerque P; Fonseca FL; Rodrigues ML
    Fungal Genet Biol; 2018 Dec; 121():46-55. PubMed ID: 30268928
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Gonçalves DS; Rodriguez de La Noval C; Ferreira MDS; Honorato L; Araújo GRS; Frases S; Pizzini CV; Nosanchuk JD; Cordero RJB; Rodrigues ML; Peralta JM; Nimrichter L; Guimarães AJ
    Front Cell Infect Microbiol; 2020; 10():565571. PubMed ID: 33585262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan.
    Fonseca FL; Frases S; Casadevall A; Fischman-Gompertz O; Nimrichter L; Rodrigues ML
    Fungal Genet Biol; 2009; 46(6-7):496-505. PubMed ID: 19285564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of Secreted Carbohydrates that Present Immunologic Similarities with the Cryptococcus Glucuronoxylomannan by Members of the Trichosporonaceae Family: A Comparative Study Among Species of Clinical Interest.
    de Andrade IB; Almeida MA; Figueiredo-Carvalho MHG; Coelho RA; Chaves ALDS; Frases S; Zancopé-Oliveira RM; Brito-Santos F; Almeida-Paes R
    Mycopathologia; 2021 Jun; 186(3):377-385. PubMed ID: 33956292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.
    Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML
    Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties.
    Ramos CL; Fonseca FL; Rodrigues J; Guimarães AJ; Cinelli LP; Miranda K; Nimrichter L; Casadevall A; Travassos LR; Rodrigues ML
    Eukaryot Cell; 2012 Sep; 11(9):1086-94. PubMed ID: 22562469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.
    Fonseca FL; Nohara LL; Cordero RJ; Frases S; Casadevall A; Almeida IC; Nimrichter L; Rodrigues ML
    Infect Immun; 2010 Sep; 78(9):3861-70. PubMed ID: 20547742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in
    Reis FCG; Borges BS; Jozefowicz LJ; Sena BAG; Garcia AWA; Medeiros LC; Martins ST; Honorato L; Schrank A; Vainstein MH; Kmetzsch L; Nimrichter L; Alves LR; Staats CC; Rodrigues ML
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30894430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
    da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
    Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated recognition of Cryptococcus neoformans.
    Levitz SM
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(3):133-6. PubMed ID: 12145626
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.
    Albuquerque PC; Fonseca FL; Dutra FF; Bozza MT; Frases S; Casadevall A; Rodrigues ML
    Future Microbiol; 2014; 9(2):147-61. PubMed ID: 24571070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil.
    Dal Pupo HD; Sena BAG; Reis FCG; Machado L; Fortes ST; de Almeida Junior JN; Godinho RMC; Rodrigues ML
    Fungal Biol; 2019 Oct; 123(10):699-708. PubMed ID: 31542188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo.
    Yauch LE; Mansour MK; Shoham S; Rottman JB; Levitz SM
    Infect Immun; 2004 Sep; 72(9):5373-82. PubMed ID: 15322035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased release of glucuronoxylomannan antigen and induced phenotypic changes in Trichosporon asahii by repeated passage in mice.
    Karashima R; Yamakami Y; Yamagata E; Tokimatsu I; Hiramatsu K; Nasu M
    J Med Microbiol; 2002 May; 51(5):423-432. PubMed ID: 11990495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
    Yauch LE; Lam JS; Levitz SM
    PLoS Pathog; 2006 Nov; 2(11):e120. PubMed ID: 17096589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.
    Kozel TR; Levitz SM; Dromer F; Gates MA; Thorkildson P; Janbon G
    Infect Immun; 2003 May; 71(5):2868-75. PubMed ID: 12704160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.
    Grijpstra J; Gerwig GJ; Wösten H; Kamerling JP; de Cock H
    Eukaryot Cell; 2009 Aug; 8(8):1165-73. PubMed ID: 19542308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration.
    Ellerbroek PM; Lefeber DJ; van Veghel R; Scharringa J; Brouwer E; Gerwig GJ; Janbon G; Hoepelman AI; Coenjaerts FE
    J Immunol; 2004 Dec; 173(12):7513-20. PubMed ID: 15585878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.
    McFadden DC; Fries BC; Wang F; Casadevall A
    Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.